Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III, Randomised, Double-Blind Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnoea Who Are Intolerant, Non-Compliant, or Naïve to Positive Airway Pressure

NCT06146101 is registered in ClinicalTrials.gov with Incannex Healthcare Ltd as lead sponsor.

NCT NCT06146101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06146101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III, Randomised, Double-Blind Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnoea Who Are Intolerant, Non-Compliant, or Naïve to Positive Airway Pressure
Lead sponsor
Incannex Healthcare Ltd
Phase
Phase 2/3
Overall status
Completed
Start date
May 2, 2024
Completion date
July 27, 2025
Enrollment
121 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea